Found: 5
Select item for more details and to access through your institution.
Correction of Experimental Hypertensive Neuroretinopathy with Semax.
- Published in:
- Journal of Pharmaceutical Negative Results, 2022, v. 13, n. 3, p. 41, doi. 10.47750/pnr.2022.13.03.007
- By:
- Publication type:
- Article
Review of a new concept of glaucoma pathogenesis based on the glymphatic theory of cerebrospinal fluid circulation.
- Published in:
- Research Results in Pharmacology, 2020, v. 6, n. 3, p. 1, doi. 10.3897/rrpharmacology.6.53634
- By:
- Publication type:
- Article
Correction of retinal ischemic injuries by using non-selective imidazoline receptor agonists in the experiment.
- Published in:
- Research Results in Pharmacology, 2019, v. 5, n. 4, p. 7, doi. 10.3897/rrpharmacology.5.38498
- By:
- Publication type:
- Article
Pharmacological correction of morphofunctional retinal injury using 11-amino acid fragment of darbepoetin in the experiment.
- Published in:
- Research Results in Pharmacology, 2019, v. 5, n. 3, p. 43, doi. 10.3897/rrpharmacology.5.38730
- By:
- Publication type:
- Article
Protective effects of 11-amino acid darbepoetin fragment in the experimental hypertensive neuroretinopathy.
- Published in:
- Drug Invention Today, 2019, v. 12, n. 11, p. 2726
- By:
- Publication type:
- Article